{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:52:29Z","timestamp":1792101149772,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 19K08755"],"award-info":[{"award-number":["JP 19K08755"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["24390276"],"award-info":[{"award-number":["24390276"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["ippan-081"],"award-info":[{"award-number":["ippan-081"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.alit.2019.03.006","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T01:09:51Z","timestamp":1555376991000},"page":"301-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":261,"title":["Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019"],"prefix":"10.1016","volume":"68","author":[{"given":"Tetsuo","family":"Shiohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Mizukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2019.03.006_bib1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM195006082422304","article-title":"Dilantin hypersensitivity: report of a case of hepatitis with jaundice, pyrexia, exfoliative dermatitis","volume":"242","author":"Chaiken","year":"1950","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2019.03.006_bib2","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI113798","article-title":"Anticonvulsant hypersensitivity syndrome. In\u00a0vitro assessment of risk","volume":"82","author":"Shear","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.alit.2019.03.006_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.alit.2019.03.006_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DiHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2019.03.006_bib5","series-title":"Drug Hypersensitivity","first-page":"251","article-title":"Drug-induced hypersensitivity syndrome and viral infection","author":"Shiohara","year":"2007"},{"key":"10.1016\/j.alit.2019.03.006_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archderm.134.9.1108","article-title":"Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome","volume":"134","author":"Suzuki","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archderm.134.9.1113","article-title":"Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6","volume":"134","author":"Tohyama","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","article-title":"Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","volume":"157","author":"Tohyama","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib13","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.amjmed.2011.10.027","article-title":"Human herhesvirus 6 reactivation in drug-induced hypersensitivity syndrome and DRESS validation score","volume":"125","author":"Ushigome","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.alit.2019.03.006_bib14","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","article-title":"Drug-induced hypersensitivity syndrome(DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS) severity score: a useful tool for assessing disease severity and predicting fatal cytomegalovirus disease","volume":"80","author":"Mizukawa","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib15","first-page":"131","article-title":"Phenytoin-induced systemic granulomatous vasculitis","volume":"110","author":"Gaffey","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.alit.2019.03.006_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8421-3","article-title":"Crucial role of viral reactivation in the development of severe drug eruptions: a comprehensive review","volume":"49","author":"Shiohara","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.alit.2019.03.006_bib17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/17425255.2017.1297422","article-title":"Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"13","author":"Shiohara","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.alit.2019.03.006_bib18","series-title":"Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions. Current and Future Trends","first-page":"55","article-title":"Viral reactivation in cutaneous adverse drug reactions","author":"Shiohara","year":"2019"},{"key":"10.1016\/j.alit.2019.03.006_bib19","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.alit.2019.03.006_bib20","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.alit.2019.03.006_bib21","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","article-title":"Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population","volume":"20","author":"Ozeki","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.alit.2019.03.006_bib22","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2019.03.006_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jamaneurol.2018.0278","article-title":"Association of HLA-A*31:01 screening with the incidence of carbamazepine-induced cutaneous adverse reactions in Japanese population","volume":"75","author":"Mushiroda","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.alit.2019.03.006_bib24","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruption: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2019.03.006_bib25","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/cea.13252","article-title":"Monocytes are involved in the balance between regulatory T cells and Th17 cells in severe drug eruptions","volume":"48","author":"Ushigome","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2019.03.006_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors","volume":"33","author":"Cros","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2019.03.006_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2010.09.007","article-title":"Diversity: a hallmark of monocyte society","volume":"33","author":"van de Veerdonk","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2019.03.006_bib28","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2012-06-434605","article-title":"CD16+ monocytes control T-cell subset development in immune thrombocytopenia","volume":"120","author":"Zhong","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.alit.2019.03.006_bib29","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1001\/archderm.1991.01680080097009","article-title":"Generalized postulation as a manifestation of the anticonvulsant hypersensitivity syndrome","volume":"127","author":"Kleter","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","article-title":"The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the elicitation drug","volume":"29","author":"Kano","year":"2009","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.alit.2019.03.006_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jaad.2006.02.050","article-title":"Hypogammagulobulinemia as an early sign of drug-induced hypersensitivity syndrome","volume":"55","author":"Kano","year":"2006","journal-title":"J\u00a0Am Acad Dematol"},{"key":"10.1016\/j.alit.2019.03.006_bib32","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/all.12410","article-title":"The dynamics of herpesvirus reactivation during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome","volume":"69","author":"Ishida","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2019.03.006_bib33","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2019.03.006_bib34","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1182\/blood-2010-11-317321","article-title":"Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells","volume":"117","author":"Hoechst","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.alit.2019.03.006_bib35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.alit.2019.03.006_bib36","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archdermatol.2009.195","article-title":"Cytomegalovirus disease during severe drug eruptions: report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome","volume":"145","author":"Asano","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib37","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jaad.2010.11.057","article-title":"A\u00a0review of DRESS-associated myocarditis","volume":"66","author":"Bourgeois","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib38","first-page":"124","article-title":"Multiple cavities with halo sign in a case of invasive pulmonary aspergillosis during therapy for drug-induced hypersensitivity syndrome","volume":"21","author":"Ikari","year":"2017","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.alit.2019.03.006_bib39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1346-8138.2005.tb00762.x","article-title":"Drug-induced hypersensitivity syndrome due to mexiletine-associated with human herpes virus 6 and cytomegalovirus reactivation","volume":"32","author":"Sekiguchi","year":"2005","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2340\/00015555-1863","article-title":"DIHS\/DRESS with remarkable eosinophilic pneumonia caused by zonisamide","volume":"95","author":"Shibuya","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2019.03.006_bib41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2169\/internalmedicine.40.331","article-title":"Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia","volume":"40","author":"Arakawa","year":"2001","journal-title":"Intern Med"},{"key":"10.1016\/j.alit.2019.03.006_bib42","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4103\/0019-5154.91850","article-title":"DRESS syndrome with sepsis, acute respiratory distress syndrome and pneumomediastinum","volume":"56","author":"Giri","year":"2011","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2332\/allergolint.10-RAI-0260","article-title":"Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruptions and those under immunosuppressive therapy","volume":"59","author":"Shiohara","year":"2010","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2019.03.006_bib44","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2133.2007.07784.x","article-title":"Sclerodermoid graft-versus-host disease-like lesions occurring after drug-induced hypersensitivity syndrome","volume":"156","author":"Kano","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2019.03.006_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-225528","article-title":"Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome(DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome","author":"Morita","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.alit.2019.03.006_bib46","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/bjd.14677","article-title":"Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in DiHS\/DRESS","volume":"175","author":"Takehara","year":"2016","journal-title":"Br J Dermatol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893019300462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893019300462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:55:06Z","timestamp":1778594106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893019300462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1323893019300462"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2019.03.006","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2019.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}